Bruce H. Soloway
Publications 448
Should treatment to lower blood pressure (BP) be initiated based on baseline BP, overall cardiovascular (CV) risk, or a combination of the two? In a
Among once-weekly injectable glucagon-like peptide-1 (GLP-1) inhibitors, semaglutide (Ozempic) is more effective than exenatide (Byetta) and
Glucagon-like peptide-1 (GLP-1) agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors prevent some adverse cardiovascular (CV) events in
Real-time patient access to providers through video visits (telemedicine) could lower barriers to healthcare (e.g., transportation, child care, need
Among patients with type 2 diabetes who use insulin, many have difficulty reaching their targets for glycemic control. Barriers to success include the
Hip and knee replacements are intended to provide long-term relief from pain and disability, but given enough time, prosthetic joints inevitably will
In 2016, the FDA approved the first hybrid closed-loop insulin delivery system (“artificial pancreas”) for adults and adolescents with type 1 diabetes;
Primary prevention of cardiovascular (CV) disease often fails because of poor adherence to evidence-based guidelines by both patients and clinicians.
Several randomized trials have shown that aspirin helps prevent colorectal cancer (CRC), but uncertainties remain about dosing and target populations.
In primary care, carpal tunnel syndrome (CTS) usually is diagnosed based on history and physical findings. Unless CTS is severe, it usually is treated